BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18033049)

  • 1. [Carbamazepine and clarithromycin: a clinically relevant drug interaction].
    Gélisse P; Hillaire-Buys D; Halaili E; Jean-Pastor MJ; Vespignan H; Coubes P; Crespel A
    Rev Neurol (Paris); 2007 Nov; 163(11):1096-9. PubMed ID: 18033049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatremia due to an additive effect of carbamazepine and clarithromycin.
    Kanbay M; Alkis M; Turgut F; Uz E; Bavbek N; Akcay A
    South Med J; 2007 Feb; 100(2):222. PubMed ID: 17330699
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
    Yasui N; Otani K; Kaneko S; Shimoyama R; Ohkubo T; Sugawara K
    Int Clin Psychopharmacol; 1997 Jul; 12(4):225-9. PubMed ID: 9347384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin-carbamazepine interaction in a clinical setting.
    O'Connor NK; Fris J
    J Am Board Fam Pract; 1994; 7(6):489-92. PubMed ID: 7847111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clarithromycin-carbamazepine interaction: neurological symptoms and hyponatremia].
    Alegre Herrera S; Araujo Sanabria J; Rubio Rubio JM
    An Med Interna; 1998 Jan; 15(1):48-9. PubMed ID: 9522506
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor-induced carbamazepine toxicity.
    Berbel Garcia A; Latorre Ibarra A; Porta Etessam J; Martinez Salio A; Perez Martinez D; Siaz Diaz R; Toledo Heras M
    Clin Neuropharmacol; 2000; 23(4):216-8. PubMed ID: 11020127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy.
    Specht U; May TW; Rohde M; Wagner V; Schmidt RC; Schütz M; Wolf P
    Arch Neurol; 1997 Apr; 54(4):427-31. PubMed ID: 9109744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to carbamazepine-macrolide interactions.
    Pauwels O
    Pharmacol Res; 2002 Apr; 45(4):291-8. PubMed ID: 12030792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers.
    Moore KH; Leese PT; McNeal S; Gray P; O'Quinn S; Bye C; Sale M
    Clin Ther; 2002 Apr; 24(4):583-94. PubMed ID: 12017403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug interactions of macrolides.
    Periti P; Mazzei T; Mini E; Novelli A
    Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clarithromycin on the pharmacokinetics of carbamazepine in rhesus monkeys.
    Badyal DK; Garg SK
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):581-4. PubMed ID: 11196346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury.
    Gandhi S; Fleet JL; Bailey DG; McArthur E; Wald R; Rehman F; Garg AX
    JAMA; 2013 Dec; 310(23):2544-53. PubMed ID: 24346990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin-carbamazepine interaction: a case report.
    Albani F; Riva R; Baruzzi A
    Epilepsia; 1993; 34(1):161-2. PubMed ID: 8422851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients.
    Mesdjian E; Dravet C; Cenraud B; Roger J
    Epilepsia; 1980 Oct; 21(5):489-96. PubMed ID: 6968264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of cyclosporine toxicity induced by clarithromycin.
    Spicer ST; Liddle C; Chapman JR; Barclay P; Nankivell BJ; Thomas P; O'Connell PJ
    Br J Clin Pharmacol; 1997 Feb; 43(2):194-6. PubMed ID: 9131953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS; Polk RE; Stotka JL
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.